Skip to main content
Top
Published in: Urolithiasis 4/2006

01-08-2006 | Original Paper

Chitosan does not reduce post-prandial urinary oxalate excretion

Authors: Joshua Wolf, John R. Asplin, David S. Goldfarb

Published in: Urolithiasis | Issue 4/2006

Login to get access

Abstract

Chitosan is a positively charged non-absorbable cellulose-like fibrillar biopolymer derived from shellfish which forms films with negatively charged surfaces. We hypothesized that negatively charged oxalate in the intestinal lumen could attach to the positively charged tertiary amino group of chitosan. We studied the effects of chitosan on intestinal oxalate absorption by measuring urinary oxalate excretion following an oral oxalate load with and without accompanying oral chitosan. The subjects consumed a fixed diet and collected urine for 24 h, in divided periods, during control and experimental protocols. Urine was collected with HCl and thymol as a preservative. For the control period, the subjects consumed an oxalate load, 50 g of cooked spinach, with water for lunch; the post-prandial urine collection was divided into three periods of 2 h. For the experimental period, 1 week later, the subjects consumed the same diet as that during the control period, but added 2 g of chitosan to the oxalate load. Post-prandial urinary oxalate excretion was expressed as mg oxalate/g creatinine. The spinach load was associated with a significant post-prandial increase in urinary oxalate during the control period of 25.7±12.8 mg/g creatinine. Accompanying the oxalate load with chitosan was well tolerated. There was no decrease in post-prandial urinary oxalate excretion during the experimental period: oxalate excretion rose by 31.3±16.9 mg/g creatinine (P=0.57, NS). We conclude that chitosan does not reduce acute intestinal oxalate absorption and therefore does not affect post-prandial urinary oxalate excretion.
Literature
1.
go back to reference Curhan GC (1999) Epidemiologic evidence for the role of oxalate in idiopathic nephrolithiasis. J Endourol 13:629PubMed Curhan GC (1999) Epidemiologic evidence for the role of oxalate in idiopathic nephrolithiasis. J Endourol 13:629PubMed
2.
go back to reference Pak CY, Adams-Huet B, Poindexter JR, Pearle MS, Peterson RD, Moe OW (2004) Rapid communication: relative effect of urinary calcium and oxalate on saturation of calcium oxalate. Kidney Int 66:2032PubMedCrossRef Pak CY, Adams-Huet B, Poindexter JR, Pearle MS, Peterson RD, Moe OW (2004) Rapid communication: relative effect of urinary calcium and oxalate on saturation of calcium oxalate. Kidney Int 66:2032PubMedCrossRef
3.
go back to reference Robertson WG, Hughes H (1993) Importance of mild hyperoxaluria in the pathogenesis of urolithiasis–new evidence from studies in the Arabian peninsula. Scanning Microsc 7:391PubMed Robertson WG, Hughes H (1993) Importance of mild hyperoxaluria in the pathogenesis of urolithiasis–new evidence from studies in the Arabian peninsula. Scanning Microsc 7:391PubMed
4.
go back to reference Pearle MS, Roehrborn CG, Pak CY (1999) Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol 13:679PubMedCrossRef Pearle MS, Roehrborn CG, Pak CY (1999) Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol 13:679PubMedCrossRef
5.
go back to reference Ni MC, Dunshea-Mooij C, Bennett D, Rodgers A (2005) Chitosan for overweight or obesity. Cochrane Database Syst Rev CD003892 Ni MC, Dunshea-Mooij C, Bennett D, Rodgers A (2005) Chitosan for overweight or obesity. Cochrane Database Syst Rev CD003892
6.
go back to reference Asplin JR, Parks JH, Chen MS, Lieske JC, Toback FG, Pillay SN, Nakagawa Y, Coe FL (1999) Reduced crystallization inhibition by urine from men with nephrolithiasis. Kidney Int 56:1505PubMedCrossRef Asplin JR, Parks JH, Chen MS, Lieske JC, Toback FG, Pillay SN, Nakagawa Y, Coe FL (1999) Reduced crystallization inhibition by urine from men with nephrolithiasis. Kidney Int 56:1505PubMedCrossRef
7.
go back to reference Jaeger P, Robertson WG (2004) Role of dietary intake and intestinal absorption of oxalate in calcium stone formation. Nephron Physiol 98:64CrossRef Jaeger P, Robertson WG (2004) Role of dietary intake and intestinal absorption of oxalate in calcium stone formation. Nephron Physiol 98:64CrossRef
8.
go back to reference Laminski NA, Meyers AM, Kruger M, Sonnekus MI, Margolius LP (1991) Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors. Br J Urol 68:454PubMedCrossRef Laminski NA, Meyers AM, Kruger M, Sonnekus MI, Margolius LP (1991) Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors. Br J Urol 68:454PubMedCrossRef
9.
go back to reference Yagisawa T, Chandhoke PS, Fan J (1999) Comparison of comprehensive and limited metabolic evaluations in the treatment of patients with recurrent calcium urolithiasis. J Urol 161:1449PubMedCrossRef Yagisawa T, Chandhoke PS, Fan J (1999) Comparison of comprehensive and limited metabolic evaluations in the treatment of patients with recurrent calcium urolithiasis. J Urol 161:1449PubMedCrossRef
10.
go back to reference Holmes RP, Goodman HO, Assimos DG (2001) Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59:270PubMedCrossRef Holmes RP, Goodman HO, Assimos DG (2001) Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59:270PubMedCrossRef
11.
go back to reference Berg W, Bothor C, Pirlich W, Janitzky V (1986) Influence of magnesium on the absorption and excretion of calcium and oxalate ions. Eur Urol 12:274PubMed Berg W, Bothor C, Pirlich W, Janitzky V (1986) Influence of magnesium on the absorption and excretion of calcium and oxalate ions. Eur Urol 12:274PubMed
12.
go back to reference Hess B, Jost C, Zipperle L, Takkinen R, Jaeger P (1998) High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans. Nephrol Dial Transplant 13:2241PubMedCrossRef Hess B, Jost C, Zipperle L, Takkinen R, Jaeger P (1998) High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans. Nephrol Dial Transplant 13:2241PubMedCrossRef
13.
go back to reference Lindsjo M, Fellstrom B, Ljunghall S, Wikstrom B, Danielson BG (1989) Treatment of enteric hyperoxaluria with calcium-containing organic marine hydrocolloid. Lancet 2:701PubMedCrossRef Lindsjo M, Fellstrom B, Ljunghall S, Wikstrom B, Danielson BG (1989) Treatment of enteric hyperoxaluria with calcium-containing organic marine hydrocolloid. Lancet 2:701PubMedCrossRef
14.
go back to reference Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346:77PubMedCrossRef Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346:77PubMedCrossRef
15.
go back to reference Duncan SH, Richardson AJ, Kaul P, Holmes RP, Allison MJ, Stewart CS (2002) Oxalobacter formigenes and its potential role in human health. Appl Environ Microbiol 68:3841PubMedCrossRef Duncan SH, Richardson AJ, Kaul P, Holmes RP, Allison MJ, Stewart CS (2002) Oxalobacter formigenes and its potential role in human health. Appl Environ Microbiol 68:3841PubMedCrossRef
16.
go back to reference Hoppe B, von Unruh UG, Laube N, Hesse A, Sidhu H (2005) Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria? Urol Res 33:372PubMedCrossRef Hoppe B, von Unruh UG, Laube N, Hesse A, Sidhu H (2005) Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria? Urol Res 33:372PubMedCrossRef
17.
go back to reference Lieske JC, Goldfarb DS, De Simone C, Regnier C (2005) Use of a probiotic to decrease enteric hyperoxaluria. Kidney Int 68:1244PubMedCrossRef Lieske JC, Goldfarb DS, De Simone C, Regnier C (2005) Use of a probiotic to decrease enteric hyperoxaluria. Kidney Int 68:1244PubMedCrossRef
Metadata
Title
Chitosan does not reduce post-prandial urinary oxalate excretion
Authors
Joshua Wolf
John R. Asplin
David S. Goldfarb
Publication date
01-08-2006
Publisher
Springer-Verlag
Published in
Urolithiasis / Issue 4/2006
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-006-0048-2

Other articles of this Issue 4/2006

Urolithiasis 4/2006 Go to the issue